Form 8-K - Current report:
SEC Accession No. 0001144204-14-066830
Filing Date
2014-11-12
Accepted
2014-11-12 07:31:40
Documents
1
Period of Report
2014-11-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v393956_8k.htm 8-K 28385
  Complete submission text file 0001144204-14-066830.txt   29700
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 141211083
SIC: 2836 Biological Products, (No Diagnostic Substances)